▶주메뉴 바로가기
▶본문 바로가기
[THE INVESTOR] Genosco, a US-based subsidiary of Korean bio company Oscotec, is gearing up to go public, according to industry sources on Jan. 28. The company recently sent out a request for propos...
[THE INVESTOR] LG Household & Health Care said on Jan. 24 its net profit jumped 12 percent on-year fueled by the popularity of its luxury cosmetics brands. Its net profit came to 692 billion won...
[THE INVESTOR] Korean firm Bio Leaders announced on Jan. 23 that it will set up a biotech incubating entity in Israel with venture capital firm Yozma Group. “The official contract to establish the ...
[THE INVESTOR] Hanmi Pharmaceutical said on Jan. 23 that its partner Eli Lilly would hand back its licensed new drug candidate BTK inhibitor in rheumatoid arthritis and its commercialization rights....
[THE INVESTOR] Exports of drug-manufacturing technologies by Korean pharmaceutical and bio companies reached nearly 5.3 trillion won (US$4.70 billion) in 2018, government data showed on Jan. 22. ...
[THE INVESTOR] A Seoul court approved on Jan. 22 a request by Samsung BioLogics to put on hold the execution of penalties by the financial watchdog for the company’s suspected accounting irregularit...
[THE INVESTOR] Samsung Bioepis’ Ontruzant, a breast cancer treatment biosimilar referencing Roche’s Herceptin, won US Food and Drug Administration approval on Jan. 19, expanding the list of Hercepti...
[ THE INVESTOR] Korea’s leading biosimilar firm Celltrion announced on Jan. 18 that it has won a lawsuit over invalidating Samsung Biogen’s patent on Rituxan, a blockbuster drug for treating non-Ho...
[THE INVESTOR] Korea’s largest biopharmaceutical business association announced on Jan. 17 that it aims to boost the local industry in 2019 and make it a global powerhouse. “This year, we must use ...
[THE INVESTOR] Bukwang Pharmaceutical announced on Jan. 15 that is has sold its 7.11 percent stake, worth around 39.7 billion won (US$35.40 million), in Anterogen through an after-hours block deal. ...
[THE INVESTOR] KB Investment, an affiliate of KB Financial Group, announced on Jan. 15 that it has invested US$3 million in US-based bio firm Neuroptika. Established in December last year in Boston...
[THE INVESTOR] Korean pharmaceutical company Dong-A ST announced on Jan. 14 that it aims to expand its ethical drug division by stepping up sales of Suganon. “We are hoping for Suganon’s sales to...
[THE INVESTOR] Korean bio company Tium Bio announced on Jan. 11 that it has signed an exclusive license agreement with Chiesi Group, an international research-focused health care company. Tium Bio ...
[THE INVESTOR] Korean botulinum toxin manufacturer Hugel has acquired a patent here for its technology to develop patch-type BTX, taking an innovative approach for an alternative to the convention...
[THE INVESTOR] Korean drug development startup Vivozon plans to be listed on the second-tier KOSDAQ market this year, according to industry sources on Jan. 8. “It is true that we are aiming to go p...
[Market Close-up] S. Korean stock market recovers faster than other markets
One Equity Partners to unload Celltrion Healthcare stake at discount
Local telecom firms bid for fifth-largest cable TV operator Hyundai HCN
IBK fined $86m in US over mishandling anti-money laundering program
Acleda Bank lists on KRX-invested Cambodian stock exchange
Samsung Biologics bags CMO deals worth W468b
Tmon vows to turn profit by 10th anniversary
Macrogen’s COVID-19 test kit approved for export
May 27, 2020
![[Market Close-up] S. Korean stock market recovers faster than other markets](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2020/05/27/20200527000702_0.jpg&md=20200527162557)
